Mauritania vs Saint Vincent and the Grenadines: The number of people with susceptibility test result for rifampicin
Mauritania
0
in 2021
Saint Vincent and the Grenadines
0
in 2021
Mauritania rank
146th
Saint Vincent and the Grenadines rank
146th
The number of people with susceptibility test result for rifampicin over time
- Mauritania
- Saint Vincent and the Grenadines
How they compare
Mauritania currently reports 0 against 0 in Saint Vincent and the Grenadines, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Mauritania ahead.
Mauritania ranks 146th and Saint Vincent and the Grenadines ranks 146th of 155 countries.
Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritania | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3 | 3.33 | 0.3333 | Saint Vincent and the Grenadines |
| 2020s | 0 | 6.5 | 6.5 | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mauritania or Saint Vincent and the Grenadines?
- Mauritania, at 0 against 0 in Saint Vincent and the Grenadines as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mauritania and Saint Vincent and the Grenadines?
- 0, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Saint Vincent and the Grenadines?
- 5 years are reported by both, from 2017 to 2021.
- How do Mauritania and Saint Vincent and the Grenadines rank globally for the number of people with susceptibility test result for rifampicin?
- Mauritania ranks 146th and Saint Vincent and the Grenadines ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.